deltatrials
Completed PHASE1/PHASE2 NCT00002602

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

A PHASE I/II DOSE ESCALATION STUDY USING THREE DIMENSIONAL CONFORMAL RADIATION THERAPY FOR ADENOCARCINOMA OF THE PROSTATE

Sponsor: NRG Oncology

Conditions Prostate Cancer
Interventions 3D-CRT
Updated 7 times since 2017 Last updated: Jan 8, 2020 Started: May 31, 1994 Primary completion: Mar 31, 2004 Completion: Nov 30, 2013

A PHASE1/PHASE2 clinical study on Prostate Cancer, this trial is completed. The trial is conducted by NRG Oncology and has accumulated 7 data snapshots since 1994. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  5. Feb 2020 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

▶ Show 2 earlier versions

  1. Jun 2018 — Feb 2020 [monthly]

    Completed PHASE1_PHASE2

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

    First recorded

May 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • NRG Oncology
  • National Cancer Institute (NCI)
  • Radiation Therapy Oncology Group
Data source: Radiation Therapy Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States, Albany, United States, Albuquerque, United States, Allentown, United States, Amarillo, United States, Anchorage, United States, Anderson, United States, Ann Arbor, United States, Annapolis, United States, Arlington Heights, United States and 167 more location s